The role of allopregnanolone in depressive-like behaviors: Focus on neurotrophic proteins

Allopregnanolone (3α,5α-tetrahydroprogesterone; pharmaceutical formulation: brexanolone) is a neurosteroid that has recently been approved for the treatment of postpartum depression, promising to fill part of a long-lasting gap in the effectiveness of pharmacotherapies for depressive disorders. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Almeida, Felipe Borges, Nin, Maurício Schüler, Barros, Helena Maria Tannhauser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Articles from the Special Issue on Allopregnanolone role in the neurobiology of stress and mood disorders; Edited by Graziano Pinna
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231971/
https://www.ncbi.nlm.nih.gov/pubmed/32435667
http://dx.doi.org/10.1016/j.ynstr.2020.100218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231971/
https://www.ncbi.nlm.nih.gov/pubmed/32435667
http://dx.doi.org/10.1016/j.ynstr.2020.100218

Ejemplares similares